PUMA BIOTECHNOLOGY INC shareholders Q2 2024

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 100 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2024
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,256,411$4,095,90012.21%
GREAT POINT PARTNERS LLC 1,486,544$4,846,1330.93%
Frazier Life Sciences Management, L.P. 3,062,558$9,983,9390.47%
Eversept Partners, LP 1,328,454$4,330,7600.30%
GLOBEFLEX CAPITAL L P 452,606$1,475,4960.15%
Affinity Asset Advisors, LLC 250,000$815,0000.09%
OXFORD ASSET MANAGEMENT LLP 21,007$68,4830.08%
TANG CAPITAL MANAGEMENT LLC 200,000$652,0000.07%
WINTON GROUP Ltd 300,599$979,9530.07%
GSA CAPITAL PARTNERS LLP 189,751$6190.04%
RICE HALL JAMES & ASSOCIATES, LLC 144,792$472,0220.03%
Alpine Global Management, LLC 40,116$130,7780.02%
ACADIAN ASSET MANAGEMENT LLC 1,951,208$6,3560.02%
XTX Topco Ltd 48,611$158,4720.01%
Prospera Financial Services Inc 149,570$487,5880.01%
State of Wyoming 26,963$87,8990.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 139,400$454,4440.01%
Renaissance Technologies 1,753,013$5,714,8220.01%
Schonfeld Strategic Advisors LLC 334,107$1,089,1880.01%
Patriot Financial Group Insurance Agency, LLC 11,000$35,8600.01%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2024. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.